Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 218

1.

Convergence of distinct functional networks supporting naming and semantic recognition in the left inferior frontal gyrus.

Xu Z, Shen B, Taji W, Sun P, Naya Y.

Hum Brain Mapp. 2020 Feb 17. doi: 10.1002/hbm.24953. [Epub ahead of print]

PMID:
32065445
2.

Replisome genes regulation by anti-tumor miR-101-5p in clear cell renal cell carcinoma.

Yamada Y, Nohata N, Uchida A, Kato M, Arai T, Moriya S, Mizuno K, Kojima S, Yamazaki K, Naya Y, Ichikawa T, Seki N.

Cancer Sci. 2020 Jan 23. doi: 10.1111/cas.14327. [Epub ahead of print]

3.

Pathological Study on Epithelial-Mesenchymal Transition in Silicotic Lung Lesions in Rat.

Komai M, Mihira K, Shimada A, Miyamoto I, Ogihara K, Naya Y, Morita T, Inoue K, Takano H.

Vet Sci. 2019 Aug 30;6(3). pii: E70. doi: 10.3390/vetsci6030070.

4.

Forward Processing of Object-Location Association from the Ventral Stream to Medial Temporal Lobe in Nonhuman Primates.

Chen H, Naya Y.

Cereb Cortex. 2019 Aug 13. pii: bhz164. doi: 10.1093/cercor/bhz164. [Epub ahead of print]

PMID:
31408097
5.

Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analyses.

Ohyama C, Kojima T, Kondo T, Naya Y, Inoue T, Tomita Y, Eto M, Hisasue S, Uemura H, Obara W, Kikuchi E, Sharma P, Galsky MD, Siefker-Radtke A, Grossfeld G, Collette S, Gooden K, Kimura G.

Int J Clin Oncol. 2019 Sep;24(9):1089-1098. doi: 10.1007/s10147-019-01450-w. Epub 2019 Jun 19.

PMID:
31218529
6.

Role of pre-miR-532 (miR-532-5p and miR-532-3p) in regulation of gene expression and molecular pathogenesis in renal cell carcinoma.

Yamada Y, Arai T, Kato M, Kojima S, Sakamoto S, Komiya A, Naya Y, Ichikawa T, Seki N.

Am J Clin Exp Urol. 2019 Feb 18;7(1):11-30. eCollection 2019.

7.

Micro-ribonucleic acid expression signature of metastatic castration-resistant prostate cancer: Regulation of NCAPH by antitumor miR-199a/b-3p.

Arai T, Kojima S, Yamada Y, Sugawara S, Kato M, Yamazaki K, Naya Y, Ichikawa T, Seki N.

Int J Urol. 2019 Apr;26(4):506-520. doi: 10.1111/iju.13911. Epub 2019 Feb 28.

PMID:
30818424
8.

Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p.

Arai T, Kojima S, Yamada Y, Sugawara S, Kato M, Yamazaki K, Naya Y, Ichikawa T, Seki N.

Mol Oncol. 2019 Feb;13(2):322-337. doi: 10.1002/1878-0261.12405. Epub 2018 Dec 21.

9.
10.

PSA response following the 'steroid switch' in patients with castration-resistant prostate cancer treated with abiraterone: A case report.

Kato T, Kojima S, Fujimoto A, Otsuka K, Suyama T, Hou K, Araki K, Masuda H, Yamazaki K, Komiya A, Naya Y.

Oncol Lett. 2018 Oct;16(4):5383-5388. doi: 10.3892/ol.2018.9321. Epub 2018 Aug 17.

11.

Demonstration of Mitochondrial Damage and Mitophagy in Cisplatin-Mediated Nephrotoxicity.

Ichinomiya M, Shimada A, Ohta N, Inouchi E, Ogihara K, Naya Y, Nagane M, Morita T, Satoh M.

Tohoku J Exp Med. 2018 Sep;246(1):1-8. doi: 10.1620/tjem.246.1.

12.

Molecular pathogenesis of renal cell carcinoma: Impact of the anti-tumor miR-29 family on gene regulation.

Yamada Y, Sugawara S, Arai T, Kojima S, Kato M, Okato A, Yamazaki K, Naya Y, Ichikawa T, Seki N.

Int J Urol. 2018 Nov;25(11):953-965. doi: 10.1111/iju.13783. Epub 2018 Aug 28.

13.

Regulation of antitumor miR-144-5p targets oncogenes: Direct regulation of syndecan-3 and its clinical significance.

Yamada Y, Arai T, Kojima S, Sugawara S, Kato M, Okato A, Yamazaki K, Naya Y, Ichikawa T, Seki N.

Cancer Sci. 2018 Sep;109(9):2919-2936. doi: 10.1111/cas.13722. Epub 2018 Jul 28.

14.

Anti-tumor roles of both strands of the miR-455 duplex: their targets SKA1 and SKA3 are involved in the pathogenesis of renal cell carcinoma.

Yamada Y, Arai T, Kojima S, Sugawara S, Kato M, Okato A, Yamazaki K, Naya Y, Ichikawa T, Seki N.

Oncotarget. 2018 Jun 1;9(42):26638-26658. doi: 10.18632/oncotarget.25410. eCollection 2018 Jun 1.

15.

Regulation of NCAPG by miR-99a-3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC.

Arai T, Okato A, Yamada Y, Sugawara S, Kurozumi A, Kojima S, Yamazaki K, Naya Y, Ichikawa T, Seki N.

Cancer Med. 2018 May;7(5):1988-2002. doi: 10.1002/cam4.1455. Epub 2018 Apr 2.

16.

Pathological study of pulmonary toxicity induced by intratracheally instilled Asian sand dust (Kosa): effects of lowered serum zinc level on the toxicity.

Shimada A, Miyake K, Kenmotsu Y, Ogihara K, Naya Y, Naota M, Morita T, Inoue K, Takano H.

Folia Histochem Cytobiol. 2018;56(1):38-48. doi: 10.5603/FHC.a2018.0006. Epub 2018 Mar 26.

17.

Probe-Based Confocal Laser Endomicroscopy Using Acrinol as a Novel Dye Can Be Used to Observe Cancer Nuclei of Bladder Carcinoma In Situ.

Naya Y, Takaha N, Okubo T, Shiota K, Hayashi I, Mori M, Date S, Miki T, Ukimura O.

J Endourol Case Rep. 2018 Feb 1;4(1):25-27. doi: 10.1089/cren.2017.0114. eCollection 2018.

18.

Abiraterone acetate withdrawal syndrome: Speculations on the underlying mechanisms.

Kato T, Komiya A, Yuasa J, Kaga K, Kaga M, Kojima S, Naya Y, Isaka S.

Oncol Lett. 2018 Feb;15(2):2669-2672. doi: 10.3892/ol.2017.7628. Epub 2017 Dec 14.

19.

Impact of novel oncogenic pathways regulated by antitumor miR-451a in renal cell carcinoma.

Yamada Y, Arai T, Sugawara S, Okato A, Kato M, Kojima S, Yamazaki K, Naya Y, Ichikawa T, Seki N.

Cancer Sci. 2018 Apr;109(4):1239-1253. doi: 10.1111/cas.13526. Epub 2018 Mar 9.

20.

Aberrant expression of microRNAs and the miR-1/MET pathway in canine hepatocellular carcinoma.

Lai YC, Ushio N, Rahman MM, Katanoda Y, Ogihara K, Naya Y, Moriyama A, Iwanaga T, Saitoh Y, Sogawa T, Sunaga T, Momoi Y, Izumi H, Miyoshi N, Endo Y, Fujiki M, Kawaguchi H, Miura N.

Vet Comp Oncol. 2018 Jun;16(2):288-296. doi: 10.1111/vco.12379. Epub 2018 Jan 3.

PMID:
29314614
21.

Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis.

Yamada Y, Nishikawa R, Kato M, Okato A, Arai T, Kojima S, Yamazaki K, Naya Y, Ichikawa T, Seki N.

J Hum Genet. 2018 Feb;63(2):195-205. doi: 10.1038/s10038-017-0371-1. Epub 2017 Dec 1.

PMID:
29196733
22.

Contributions of primate prefrontal cortex and medial temporal lobe to temporal-order memory.

Naya Y, Chen H, Yang C, Suzuki WA.

Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):13555-13560. doi: 10.1073/pnas.1712711114. Epub 2017 Nov 30.

23.

Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.

Okato A, Arai T, Yamada Y, Sugawara S, Koshizuka K, Fujimura L, Kurozumi A, Kato M, Kojima S, Naya Y, Ichikawa T, Seki N.

Int J Mol Sci. 2017 Sep 13;18(9). pii: E1969. doi: 10.3390/ijms18091969.

24.

Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.

Arai T, Okato A, Kojima S, Idichi T, Koshizuka K, Kurozumi A, Kato M, Yamazaki K, Ishida Y, Naya Y, Ichikawa T, Seki N.

Cancer Sci. 2017 Oct;108(10):2088-2101. doi: 10.1111/cas.13331. Epub 2017 Aug 19.

25.

Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer.

Goto Y, Kurozumi A, Arai T, Nohata N, Kojima S, Okato A, Kato M, Yamazaki K, Ishida Y, Naya Y, Ichikawa T, Seki N.

Br J Cancer. 2017 Jul 25;117(3):409-420. doi: 10.1038/bjc.2017.191. Epub 2017 Jun 22.

26.

Dual strands of pre-miR‑150 (miR‑150‑5p and miR‑150‑3p) act as antitumor miRNAs targeting SPOCK1 in naïve and castration-resistant prostate cancer.

Okato A, Arai T, Kojima S, Koshizuka K, Osako Y, Idichi T, Kurozumi A, Goto Y, Kato M, Naya Y, Ichikawa T, Seki N.

Int J Oncol. 2017 Jul;51(1):245-256. doi: 10.3892/ijo.2017.4008. Epub 2017 May 17.

PMID:
28534948
27.

Severe Hypophosphatemia Following Denosumab Administration in a Hemodialysis Patient with Progressive Prostate Cancer.

Masuda H, Kaga K, Inahara M, Araki K, Kojima S, Naya Y, Takano M.

Urol Case Rep. 2017 Apr 26;13:63-65. doi: 10.1016/j.eucr.2016.11.019. eCollection 2017 Jul.

28.

Preoperative lipiodol marking and its role on survival and complication rates of CT-guided cryoablation for small renal masses.

Hongo F, Yamada Y, Ueda T, Nakmura T, Naya Y, Kamoi K, Okihara K, Ichijo Y, Miki T, Yamada K, Ukimura O.

BMC Urol. 2017 Jan 18;17(1):10. doi: 10.1186/s12894-017-0199-1.

29.

Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study.

Kamiya N, Suzuki H, Suyama T, Kobayashi M, Fukasawa S, Sekita N, Mikami K, Nihei N, Naya Y, Ichikawa T.

Int J Clin Oncol. 2017 Apr;22(2):353-358. doi: 10.1007/s10147-016-1048-z. Epub 2016 Oct 15.

PMID:
27744487
30.

Usefulness of R.E.N.A.L Nephrometry Scoring System and Centrality Index Score for Predicting Outcome of Laparoscopic Partial Nephrectomy.

Sugiura M, Suyama T, Kanesaka M, Fujimoto A, Hou K, Araki K, Masuda H, Kojima S, Naya Y.

J Laparoendosc Adv Surg Tech A. 2016 Oct;26(10):784-788. Epub 2016 Jul 19.

PMID:
27732324
31.

The microRNA signature of patients with sunitinib failure: regulation of UHRF1 pathways by microRNA-101 in renal cell carcinoma.

Goto Y, Kurozumi A, Nohata N, Kojima S, Matsushita R, Yoshino H, Yamazaki K, Ishida Y, Ichikawa T, Naya Y, Seki N.

Oncotarget. 2016 Sep 13;7(37):59070-59086. doi: 10.18632/oncotarget.10887.

32.

Declarative association in the perirhinal cortex.

Naya Y.

Neurosci Res. 2016 Dec;113:12-18. doi: 10.1016/j.neures.2016.07.001. Epub 2016 Jul 11. Review.

PMID:
27418578
33.

The roles of microRNAs in the progression of castration-resistant prostate cancer.

Kojima S, Goto Y, Naya Y.

J Hum Genet. 2017 Jan;62(1):25-31. doi: 10.1038/jhg.2016.69. Epub 2016 Jun 9. Review.

PMID:
27278789
34.

Physiological and Biochemical Responses to Continuous Saline Irrigation Inside the Abdominal Cavity in Anesthetized Pigs.

Ishii T, Igarashi T, Naya Y, Aoe T, Isono S.

J Laparoendosc Adv Surg Tech A. 2016 Aug;26(8):600-5. doi: 10.1089/lap.2015.0463. Epub 2016 May 19.

PMID:
27195464
35.

Androgen suppresses testicular cancer cell growth in vitro and in vivo.

Nakagawa H, Ueda T, Ito S, Shiraishi T, Taniguchi H, Kayukawa N, Nakanishi H, Ushijima S, Kanazawa M, Nakamura T, Naya Y, Hongo F, Kamoi K, Okihara K, Ukimura O.

Oncotarget. 2016 Jun 7;7(23):35224-32. doi: 10.18632/oncotarget.9109.

36.

Development of new therapy for canine mammary cancer with recombinant measles virus.

Shoji K, Yoneda M, Fujiyuki T, Amagai Y, Tanaka A, Matsuda A, Ogihara K, Naya Y, Ikeda F, Matsuda H, Sato H, Kai C.

Mol Ther Oncolytics. 2016 Jan 13;3:15022. doi: 10.1038/mto.2015.22. eCollection 2016.

37.

Transvesical laparoscopic surgery for double renal pelvis and ureter with or without ureterocele.

Naitoh Y, Oishi M, Kobayashi K, Yamada Y, Nakamura T, Johnin K, Hongo F, Naya Y, Okihara K, Kawauchi A.

Int J Urol. 2016 Apr;23(4):332-6. doi: 10.1111/iju.13049. Epub 2016 Feb 14.

38.

Small-Incision Laparoscopy-Assisted Surgery Under Abdominal Cavity Irrigation in a Porcine Model.

Igarashi T, Ishii T, Aoe T, Yu WW, Ebihara Y, Kawahira H, Isono S, Naya Y.

J Laparoendosc Adv Surg Tech A. 2016 Feb;26(2):122-8. doi: 10.1089/lap.2015.0461. Epub 2016 Jan 8.

39.

Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.

Nakamura T, Kawauchi A, Oishi M, Ueda T, Shiraishi T, Nakanishi H, Kamoi K, Naya Y, Hongo F, Okihara K, Miki T.

Int J Clin Oncol. 2016 Aug;21(4):791-795. doi: 10.1007/s10147-015-0934-0. Epub 2015 Dec 23.

PMID:
26701172
40.

Clinical predictors of prolonged postresection hypotension after laparoscopic adrenalectomy for pheochromocytoma.

Namekawa T, Utsumi T, Kawamura K, Kamiya N, Imamoto T, Takiguchi T, Hashimoto N, Tanaka T, Naya Y, Suzuki H, Ichikawa T.

Surgery. 2016 Mar;159(3):763-70. doi: 10.1016/j.surg.2015.09.016. Epub 2015 Oct 21.

PMID:
26477475
41.

Risk of haemolytic uraemic syndrome caused by shiga-toxin-producing Escherichia coli infection in adult women in Japan.

Fujii J, Mizoue T, Kita T, Kishimoto H, Joh K, Nakada Y, Ugajin S, Naya Y, Nakamura T, Tada Y, Okabe N, Maruyama Y, Saitoh K, Kurozawa Y.

Epidemiol Infect. 2016 Apr;144(5):952-61. doi: 10.1017/S0950268815002289. Epub 2015 Oct 16.

PMID:
26470913
42.

Laparoendoscopic Single-Site Surgery for Pediatric Urologic Disease.

Yamada Y, Naitoh Y, Kobayashi K, Fujihara A, Johnin K, Hongo F, Naya Y, Kamoi K, Okihara K, Kawauchi A, Miki T.

J Endourol. 2016 Jan;30(1):24-7. doi: 10.1089/end.2015.0130. Epub 2015 Oct 27.

PMID:
26411287
43.

MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.

Goto Y, Kojima S, Nishikawa R, Kurozumi A, Kato M, Enokida H, Matsushita R, Yamazaki K, Ishida Y, Nakagawa M, Naya Y, Ichikawa T, Seki N.

Br J Cancer. 2015 Sep 29;113(7):1055-65. doi: 10.1038/bjc.2015.300. Epub 2015 Sep 1.

44.

Risk of New-Onset Dyslipidemia After Laparoscopic Adrenalectomy in Patients with Primary Aldosteronism.

Kaga M, Utsumi T, Tanaka T, Kono T, Nagano H, Kawamura K, Kamiya N, Imamoto T, Nihei N, Naya Y, Suzuki H, Ichikawa T.

World J Surg. 2015 Dec;39(12):2935-40. doi: 10.1007/s00268-015-3197-z.

PMID:
26296835
45.

PAX2 promoted prostate cancer cell invasion through transcriptional regulation of HGF in an in vitro model.

Ueda T, Ito S, Shiraishi T, Taniguchi H, Kayukawa N, Nakanishi H, Nakamura T, Naya Y, Hongo F, Kamoi K, Okihara K, Kawauchi A, Miki T.

Biochim Biophys Acta. 2015 Nov;1852(11):2467-73. doi: 10.1016/j.bbadis.2015.08.008. Epub 2015 Aug 19.

46.

Analysis of L-type amino acid transporter in canine hepatocellular carcinoma.

Ogihara K, Naya Y, Sato R, Onda K, Ochiai H.

J Vet Med Sci. 2015 Jul;77(7):e1-2. doi: 10.1292/jvms.14-0392e.

47.

MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer.

Nishikawa R, Goto Y, Kurozumi A, Matsushita R, Enokida H, Kojima S, Naya Y, Nakagawa M, Ichikawa T, Seki N.

Int J Urol. 2015 Sep;22(9):867-77. doi: 10.1111/iju.12829. Epub 2015 Jun 7.

48.

Laparoscopic off-clamp partial nephrectomy using soft coagulation.

Hongo F, Kawauchi A, Ueda T, Fujihara-Iwata A, Nakamura T, Naya Y, Kamoi K, Okihara K, Miki T.

Int J Urol. 2015 Aug;22(8):731-4. doi: 10.1111/iju.12808. Epub 2015 May 18.

49.

The efficacy of radio-frequency ablation for metastatic lung or liver tumors of male germ cell tumors as an alternative minimally invasive therapy after salvage chemotherapy.

Naya Y, Nakamura T, Oishi M, Ueda T, Nakanishi H, Naitoh Y, Hongo F, Kamoi K, Okihara K, Tanaka O, Yamagami T, Yamada K, Miki T.

Int J Clin Oncol. 2015 Dec;20(6):1192-7. doi: 10.1007/s10147-015-0824-5. Epub 2015 Apr 30.

PMID:
25924698
50.

Clinical outcomes and histological findings of patients with advanced metastatic germ cell tumors undergoing post-chemotherapy resection of retroperitoneal lymph nodes and residual extraretroperitoneal masses.

Nakamura T, Oishi M, Ueda T, Fujihara A, Nakanishi H, Kamoi K, Naya Y, Hongo F, Okihara K, Miki T.

Int J Urol. 2015 Jul;22(7):663-8. doi: 10.1111/iju.12760. Epub 2015 Apr 6.

Supplemental Content

Support Center